NCT04793204View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

May 21, 2021

Study Completion Date

May 21, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

fezolinetant

oral

Trial Locations (1)

Unknown

Site CN86001, Bei'jing

All Listed Sponsors
lead

Astellas Pharma China, Inc.

INDUSTRY

NCT04793204 - A Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects | Biotech Hunter | Biotech Hunter